Burnaby, Canada

Maria Rosaria Di Fluri

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Anormed, Inc., Genzyme Corporation. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Rosaria Di Fluri. Retrieved from https://idiyas.com/inventor/maria-rosaria-di-fluri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 33.3


Average Co-Inventor Count = 13.6

ph-index = 4

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Sure, here is the article about inventor Maria Rosaria Di Fluri:

Title: Maria Rosaria Di Fluri - Pioneering Chemokine Receptor Binding Compounds Inventor

Introduction:

Maria Rosaria Di Fluri, a brilliant inventor hailing from Burnaby, CA, has made significant strides in the field of pharmaceuticals with her groundbreaking innovations in chemokine receptor binding compounds.

Latest Patents:

With a total of 9 patents to her name, Maria's latest patents include "Chemokine receptor binding heterocyclic compounds with enhanced efficacy" and "Chemokine receptor binding heterocyclic compounds," which have demonstrated protective effects against HIV infection by binding to chemokine receptors like CXCR4 and CCR5.

Career Highlights:

Maria has had a remarkable career working with prestigious companies such as Anormed, Inc. and Genzyme Corporation, where she has contributed immensely to the development of revolutionary pharmaceutical compounds that have the potential to change the landscape of HIV treatment.

Collaborations:

Throughout her career, Maria has collaborated with esteemed professionals in the field, including Gary James Bridger and David Earl Bogucki, who have played crucial roles in bringing her innovative ideas to fruition.

Conclusion:

In conclusion, Maria Rosaria Di Fluri's dedication to advancing pharmaceutical science through her inventive chemokine receptor binding compounds showcases her as a trailblazer in the industry. Her commitment to improving the lives of those affected by HIV is truly inspirational, making her a role model for aspiring inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…